Table 2 Prevalence of fungal and bacterial pathogens from respiratory samples
COVID-19 | Non COVID-19 | p value | OR | 95% CI | |
|---|---|---|---|---|---|
CoNS, N (%) | 10 (2.3) | 5 (1.7) | 0.75 | 1.38 | 0.47–4.09 |
Enterobacterales, N (%) | 101 (22.9) | 102 (33.7) | 0.002 | 0.59 | 0.42–0.81 |
Enterococcus spp., N (%) | 35 (7.9) | 7 (2.3) | 0.002 | 3.65 | 1.6–8.32 |
GN-NFB, N (%) | 12 (2.7) | 19 (6.3) | 0.03 | 0.42 | 0.2–0.88 |
Haemophilus spp., N (%) | 1 (0.2) | 11 (3.6) | < 0.001 | 0.06 | 0.01–0.47 |
Pseudomonas spp., N (%) | 114 (25.9) | 40 (13.2) | < 0.001 | 2.29 | 1.54–3.4 |
Staphylococcus aureus, N (%) | 50 (11.3) | 37 (12.2) | 0.8 | 0.92 | 0.59–1.45 |
Streptococcus spp., N (%) | 3 (0.7) | 9 (3.0) | 0.03 | 0.22 | 0.06–0.83 |
Other pathogens, N (%) | 8 (1.8) | 8 (2.6) | 0.61 | 0.68 | 0.26–1.89 |
Aspergillus spp., N (%) | 48 (10.9) | 21 (6.9) | 0.09 | 1.64 | 0.96–2.8 |
Candida spp., N (%) | 59 (13.4) | 44 (14.5) | 0.13 | 0.73 | 0.6–1.39 |
Total | 441 | 303 | – | – | – |